Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Healthcare Industry News LUMA Vision clears FDA hurdle as VERAFEYE targets an early 2027 U.S. launch LUMA Vision has secured expanded FDA clearance for VERAFEYE, combining real-time 3D cardiac anatomy, catheter tracking and ablation guidance ahead of a planned commercial launch in early 2027. byVenkateshSeptember 14, 2026